Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

Similar articles for PubMed (Select 1346255)

1.

p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.

Cancer Res. 1992 Feb 1;52(3):674-9.

2.

Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro.

Witusik-Perkowska M, Zakrzewska M, Szybka M, Papierz W, Jaskolski DJ, Liberski PP, Sikorska B.

Cancer Cell Int. 2014 Aug 22;14:82. doi: 10.1186/s12935-014-0082-z. eCollection 2014.

3.

Genetic analysis of a case of glioblastoma with oligodendroglial component arising during the progression of diffuse astrocytoma.

Hata N, Suzuki SO, Murata H, Hatae R, Akagi Y, Sangatsuda Y, Amano T, Yoshimoto K, Tahira T, Mizoguchi M.

Pathol Oncol Res. 2015 Jul;21(3):839-43. doi: 10.1007/s12253-014-9850-2. Epub 2014 Oct 30.

PMID:
25354913
4.

Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.

Kortüm KM, Langer C, Monge J, Bruins L, Egan JB, Zhu YX, Shi CX, Jedlowski P, Schmidt J, Ojha J, Bullinger L, Liebisch P, Kull M, Champion MD, Van Wier S, Ahmann G, Rasche L, Knop S, Fonseca R, Einsele H, Stewart AK, Braggio E.

Br J Haematol. 2015 Feb;168(4):507-10. doi: 10.1111/bjh.13171. Epub 2014 Oct 10.

5.

Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.

Ohta T, Kim YH, Oh JE, Satomi K, Nonoguchi N, Keyvani K, Pierscianek D, Sure U, Mittelbronn M, Paulus W, Vital A, Yokoo H, McDonald K, Kleihues P, Nazaret N, Barbet F, Lachuer J, Ohgaki H.

J Neuropathol Exp Neurol. 2014 Oct;73(10):908-15. doi: 10.1097/NEN.0000000000000110.

PMID:
25192052
6.

Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.

Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, Bechet D, Faury D, De Jay N, Ramkissoon LA, Corcoran A, Jones DT, Sturm D, Johann P, Tomita T, Goldman S, Nagib M, Bendel A, Goumnerova L, Bowers DC, Leonard JR, Rubin JB, Alden T, Browd S, Geyer JR, Leary S, Jallo G, Cohen K, Gupta N, Prados MD, Carret AS, Ellezam B, Crevier L, Klekner A, Bognar L, Hauser P, Garami M, Myseros J, Dong Z, Siegel PM, Malkin H, Ligon AH, Albrecht S, Pfister SM, Ligon KL, Majewski J, Jabado N, Kieran MW.

Nat Genet. 2014 May;46(5):462-6. doi: 10.1038/ng.2950. Epub 2014 Apr 6.

7.

Neuro-oncology: Novel biomarkers for high-grade astrocytoma.

Malkki H.

Nat Rev Neurol. 2014 Mar;10(3):121. doi: 10.1038/nrneurol.2014.21. Epub 2014 Feb 11. No abstract available.

PMID:
24514869
8.

A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma.

Rao SA, Srinivasan S, Patric IR, Hegde AS, Chandramouli BA, Arimappamagan A, Santosh V, Kondaiah P, Rao MR, Somasundaram K.

PLoS One. 2014 Jan 24;9(1):e85200. doi: 10.1371/journal.pone.0085200. eCollection 2014.

9.

Identification of novel genetic alterations in samples of malignant glioma patients.

Milinkovic V, Bankovic J, Rakic M, Stankovic T, Skender-Gazibara M, Ruzdijic S, Tanic N.

PLoS One. 2013 Dec 16;8(12):e82108. doi: 10.1371/journal.pone.0082108. eCollection 2013.

10.

IDH2 and TP53 mutations are correlated with gliomagenesis in a patient with Maffucci syndrome.

Moriya K, Kaneko MK, Liu X, Hosaka M, Fujishima F, Sakuma J, Ogasawara S, Watanabe M, Sasahara Y, Kure S, Kato Y.

Cancer Sci. 2014 Mar;105(3):359-62. doi: 10.1111/cas.12337.

PMID:
24344754
11.

The genetic landscape of anaplastic astrocytoma.

Killela PJ, Pirozzi CJ, Reitman ZJ, Jones S, Rasheed BA, Lipp E, Friedman H, Friedman AH, He Y, McLendon RE, Bigner DD, Yan H.

Oncotarget. 2014 Mar 30;5(6):1452-7.

12.

Evolutionary etiology of high-grade astrocytomas.

Song Y, Zhang Q, Kutlu B, Difilippantonio S, Bash R, Gilbert D, Yin C, O'Sullivan TN, Yang C, Kozlov S, Bullitt E, McCarthy KD, Kafri T, Louis DN, Miller CR, Hood L, Van Dyke T.

Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17933-8. doi: 10.1073/pnas.1317026110. Epub 2013 Oct 10.

13.

MAPping the genomic landscape of low-grade pediatric gliomas.

Turcan S, Chan TA.

Nat Genet. 2013 Aug;45(8):847-9. doi: 10.1038/ng.2706.

PMID:
23892663
14.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, Gronych J, Lasitschka B, Schmidt S, Seker-Cin H, Witt H, Sultan M, Ralser M, Northcott PA, Hovestadt V, Bender S, Pfaff E, Stark S, Faury D, Schwartzentruber J, Majewski J, Weber UD, Zapatka M, Raeder B, Schlesner M, Worth CL, Bartholomae CC, von Kalle C, Imbusch CD, Radomski S, Lawerenz C, van Sluis P, Koster J, Volckmann R, Versteeg R, Lehrach H, Monoranu C, Winkler B, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, Ebinger M, Schuhmann MU, Cho YJ, Pomeroy SL, von Deimling A, Witt O, Taylor MD, Wolf S, Karajannis MA, Eberhart CG, Scheurlen W, Hasselblatt M, Ligon KL, Kieran MW, Korbel JO, Yaspo ML, Brors B, Felsberg J, Reifenberger G, Collins VP, Jabado N, Eils R, Lichter P, Pfister SM; International Cancer Genome Consortium PedBrain Tumor Project.

Nat Genet. 2013 Aug;45(8):927-32. doi: 10.1038/ng.2682. Epub 2013 Jun 30.

15.

High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Smardova J, Liskova K, Ravcukova B, Kubiczkova L, Sevcikova S, Michalek J, Svitakova M, Vybihal V, Kren L, Smarda J.

Pathol Oncol Res. 2013 Jul;19(3):421-8. doi: 10.1007/s12253-012-9596-7. Epub 2013 Mar 28.

PMID:
23536279
16.

H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.

Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T.

Am J Clin Pathol. 2013 Mar;139(3):345-9. doi: 10.1309/AJCPABOHBC33FVMO.

17.

The definition of primary and secondary glioblastoma.

Ohgaki H, Kleihues P.

Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi: 10.1158/1078-0432.CCR-12-3002. Epub 2012 Dec 3. Review.

18.

[Clinical and pathologic analysis of astrocytic tumors with loss of heterozygosity on chromosome 10q].

Zhou FA, Li JZ, Ma YQ, Miao N, Liu X, Li XX, Zhang W.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):618-21. doi: 10.3760/cma.j.issn.0529-5807.2012.09.010. Chinese.

PMID:
23157831
19.

TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.

Faria MH, Neves Filho EH, Alves MK, Burbano RM, de Moraes Filho MO, Rabenhorst SH.

APMIS. 2012 Nov;120(11):882-9. doi: 10.1111/j.1600-0463.2012.02918.x. Epub 2012 May 18.

PMID:
23009112
20.

p53 isoform profiling in glioblastoma and injured brain.

Takahashi R, Giannini C, Sarkaria JN, Schroeder M, Rogers J, Mastroeni D, Scrable H.

Oncogene. 2013 Jun 27;32(26):3165-74. doi: 10.1038/onc.2012.322. Epub 2012 Jul 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk